Novel imaging and AI technology predicts lung cancer gene mutations to guide targeted treatment
AI-powered fluorescence imaging predicts actionable lung cancer mutations without genetic testing
AI-powered fluorescence imaging predicts actionable lung cancer mutations without genetic testing
Leading experts from Geisinger and Cepheid to share practical strategies for improving gastrointestinal diagnostic accuracy and stewardship
Last chance to vote for the products that have made the most difference to the clinical lab and be in with a chance to win a $100 Amazon Gift Card (or equivalent currency)
Understand the case for NHS pathology network transformation and the challenges facing UK labs
Fujirebio Europe N.V. explains how the full integration of ADx NeuroSciences strengthens its end-to-end model for neurological biomarker development, from early discovery to routine clinical application
Launches include the first commercially available singleplex eMTBR-Tau immunoassay, a novel pTau 217 assay for venous and capillary blood, and a fully automated instrument platform
Roche will showcase new trontinemab clinical data, Phase III prevention studies, neuroinflammatory research, and blood-based Alzheimer’s diagnostics including Elecsys® pTau217 and pTau181
New program to develop rapid diagnostic test for rare Bundibugyo Ebola strain during largest outbreak on record
Screening tools are becoming vital in the fight against Candida auris, a rapidly spreading and deadly fungal infection with growing antifungal resistance
Combining proteomics with multiomics workflows is helping researchers move beyond single markers and toward a more connected view of immune dysregulation, patient subtypes, and disease activity
Assay enables laboratories across Europe and other CE-recognizing markets to scale blood-based Alzheimer’s disease testing and advance research into amyloid and tau pathology
New system improves sample traceability and slide labeling in cancer diagnostics
Milestone deployment reflects growing demand for high-throughput, AI-enabled digital pathology workflows
The test is being developed for use on Abbott’s Alinity ci-series systems to help enable earlier and more accessible Alzheimer’s diagnosis on a global scale
Algocyte launches PROXIMA™, the UKs first designed and manufactured full blood count analyser, bringing AI-powered, patient-centric blood monitoring closer to home
Automated immunoassays and component-level testing support more precise allergy diagnostics
Digital platform improves quality control visibility and decision-making in clinical labs
New thinking around Bayes’ theorem, sepsis biomarkers, and additive diagnostic value could help unlock tests that improve patient care, even when they fall short of perfection
New drug testing panel supports rapid, automated screening of 15 drugs of abuse in clinical and critical care settings
Enhanced antibody detection supports more informed transplant matching decisions
Automated blood culture system improves detection speed and supports earlier sepsis diagnosis
New assay identifies patients with PTEN protein loss who may benefit from targeted treatment
Tiny algae-based robots improve tumour drug penetration and reduce tumour burden in preclinical study
Peristaltic pump technologies support accurate flow control and GMP-compliant medical device manufacturing
Flexible, end‑to‑end CDx development framework integrates digital pathology and clinical workflows to accelerate commercialization